|Articles|May 1, 2000

CME: Pediatrics and the Human Genome Project

A massive undertaking to determine the sequence of the several billion DNA building blocks that represent the human genome is almost complete. Pediatricians can look forward to new molecular tests for diagnosing inherited disorders in the near future. Novel therapies should follow.

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

CME: Pediatrics and the Human Genome Project

Related Content

Top 5 pediatric health headlines you missed in May 2026

Supporting children with hidradenitis suppurativa beyond medical treatment, with Colleen Cotton, MD

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults

Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults

Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa

Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa

FDA accepts mavacamten (Camzyos) application for adolescent obstructive hypertrophic cardiomyopathy